Cancer of the Tongue Treatment in Turkey

What Cancer of the Tongue Is and Typical Symptoms

Cancer of the tongue is a head and neck malignancy that arises from the epithelial cells lining the tongue tissue. The overwhelming majority of cases are squamous cell carcinomas. Clinically, doctors divide the tongue into two distinct anatomical regions: the oral tongue, which encompasses the anterior two-thirds located within the mouth, and the base of the tongue, which forms the posterior third situated in the oropharynx. While oral tongue malignancies are often linked to chronic tobacco and alcohol irritation or dental friction, base of tongue tumours frequently correlate with persistent Human Papillomavirus (HPV) infection.

In its initial stages, tongue cancer may present subtly. International patients commonly seek medical evaluation through an ENT (Ear, Nose & Throat) clinic or an oncology department after noticing one or more persistent symptoms:

• A non-healing ulcer, sore, or firm lump on the tongue lasting longer than three weeks.
• Red patches (erythroplakia) or white plaques (leukoplakia) inside the mouth.
• Persistent tongue discomfort, burning, or pain radiating toward the ear.
• Restricted tongue mobility or stiffness that alters speech clarity or chewing.
• Difficulty or pain when swallowing liquids or solid food.
• A non-tender, enlarged lymph node in the neck.

How Cancer of the Tongue Is Diagnosed

Accurate staging and histopathology dictate every clinical decision. Hospitals in Turkey follow international oncological guidelines to assess the primary tumour, regional lymph nodes, and potential metastasis.

The standard diagnostic workup includes endoscopic examination of the upper aerodigestive tract to inspect the tongue base and larynx. A tissue biopsy is essential; pathologists examine specimens to confirm squamous cell carcinoma, determine tumour grade, and test for p16/HPV status. Staging requires contrast-enhanced magnetic resonance imaging (MRI) of the head and neck to assess tumour depth and muscle invasion. Computed tomography (CT) or PET-CT scans identify whether cancer has reached cervical lymph nodes or distant organs, often coordinated through check-ups & diagnostics departments.

Patients also undergo dental evaluation. Because radiation can permanently reduce saliva and affect jawbone vascularity, preventive dental treatments are completed before radiotherapy begins.

International patients should bring:

• Diagnostic pathology glass slides, tissue blocks, and formal pathology reports.
• Digital imaging files (DICOM) on disc or USB for previous CT, MRI, or PET scans.
• Surgical notes and discharge letters from prior interventions.
• A list of current medications and summary of cardiovascular and pulmonary health.

Treatment Options and When Each Is Used

Treatment for tongue cancer is planned by a multidisciplinary tumour board including head and neck surgeons, radiation oncologists, medical oncologists, and reconstructive specialists. Care plans depend on tumour location, stage, depth of invasion, and overall health.

For resectable disease, wide local excision or partial glossectomy remains a primary approach. When tumours invade deeper muscle layers, reconstruction using microvascular free flaps is coordinated with plastic & aesthetic surgery specialists to preserve speech and swallowing. Following primary treatment, structured rehabilitation with speech and language therapists assists in retraining swallowing reflexes.

Planning Your Treatment in Turkey

Undergoing cancer care abroad requires careful preparation. Patients begin by sending detailed medical records and diagnostic scans for review by a hospital tumour board before travelling. In Turkey, doctors perform confirmatory clinical examinations, repeat imaging if existing scans lack sufficient resolution, and re-examine biopsy slides.

Hospital stay and travel duration depend on the treatment chosen. Patients having surgical resection typically stay in Turkey for 14 to 21 days to allow wound healing, drain removal, and flap monitoring. If definitive chemoradiotherapy is recommended, a continuous stay of seven to eight weeks is necessary to complete daily radiation sessions and manage acute side effects. Before departure, the treating team provides comprehensive medical records in English and instructions for follow-up care with your doctor at home.

When Travel Is Not Advisable and Warning Signs

Travelling abroad for treatment is not advisable under certain clinical conditions. You should not travel if you experience:

• Airway obstruction, stridor, or severe shortness of breath caused by tumour swelling.
• Active oral bleeding or tumour proximity to major neck vessels presenting high haemorrhage risk.
• Severe dehydration, severe malnutrition, or inability to take fluids without enteral feeding support.
• Uncontrolled systemic infection or unstable heart or lung disease.

If you develop heavy oral bleeding, acute breathing difficulty, sudden inability to swallow, or high fever with chest symptoms, seek immediate emergency care at your nearest hospital rather than attempting international travel.